George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

UPDATE: FDA Approves Vaccines for 2010-11 Flu Season

Fri, 30th Jul 2010 19:57

(Update in last paragraph with list of companies making the flu vaccine.) By Shayndi Raice Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--The U.S. Food and Drug Administration announced Friday it has approved vaccines for the 2010-2011 flu season. The latest flu vaccine will prevent against three strains of influenza, including the H1N1 virus, or swine flu, that caused last year's pandemic. Karen Midthun, acting director of the FDA's center for biologics evaluation and research, said the best way to protect against the flu is to get vaccinated annually. "The availability of a new seasonal influenza vaccine each year is an important tool in the prevention of influenza related illnesses and death," she added. Because H1N1 developed after the flu vaccine was produced, a separate vaccine to address swine flu was needed. The FDA's approval means that only one vaccine will be required for all strains of influenza. Companies that will be producing a version of the vaccine include CSL Limited (CSL), Novartis Vaccines and Diagnostics (NOVN), GlaxoSmithKline Biologicals (GSK), ID Biomedical Corporation, MedImmune Vaccines Inc., and Sanofi Pasteur Inc. (SNY). -By Shayndi Raice, Dow Jones Newswires; 202-862-9291; shayndi.raice@dowjones.com (END) Dow Jones Newswires July 30, 2010 14:57 ET (18:57 GMT)

Related Shares

More News
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related...

24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application ...

24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jempe...

17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.